# Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine

> **NCT01101074** · — · COMPLETED · sponsor: **Novartis Vaccines** · enrollment: 135469 (actual)

## Conditions studied

- Influenza A (H1N1)

## Interventions

- **OTHER:** This is non-intervention observational study

## Key facts

- **NCT ID:** NCT01101074
- **Lead sponsor:** Novartis Vaccines
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-09
- **Target enrollment:** 135469 (ACTUAL)
- **Last updated:** 2011-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101074, "Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01101074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
